An integrative analysis to distinguish between emphysema (EML) and alpha-1 antitrypsin deficiency-related emphysema (ADL)-A systems biology approach

被引:14
|
作者
Kumar, S. Udhaya [1 ]
Priya, N. Madhana [2 ]
Kumar, D. Thirumal [3 ]
Preethi, V. Anu [4 ]
Kumar, Vibhaa [1 ]
Nagarajan, Dhanushya [1 ]
Magesh, R. [2 ]
Younes, Salma [5 ]
Zayed, Hatem [5 ]
Doss, C. George Priya [1 ]
机构
[1] Vellore Inst Technol, Sch BioSci & Technol, Vellore, Tamil Nadu, India
[2] Sri Ramachandra Inst Higher Educ & Res DU, Dept Biotechnol, Chennai, Tamil Nadu, India
[3] Meenakshi Acad Higher Educ & Res, Chennai, Tamil Nadu, India
[4] Vellore Inst Technol, Sch Comp Sci & Engn, Vellore, Tamil Nadu, India
[5] Qatar Univ, Coll Hlth & Sci, QU Hlth, Dept Biomed Sci, Doha, Qatar
来源
关键词
EXPRESSION; GENE; CYTOSCAPE; CELLS; MITOCHONDRIA; NETWORK; RANTES;
D O I
10.1016/bs.apcsb.2021.02.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Lung Emphysema is an abnormal enlargement of the air sacs followed by the destruction of alveolar walls without any prominent fibrosis. This study primarily identifies the differentially expressed genes (DEGs), interactions between them, and their significant involvement in the activated signaling cascades. The dataset with ID GSE1122 (five normal lung tissue samples, five of usual emphysema, and five of alpha-1 antitrypsin deficiency-related emphysema) from the gene expression omnibus (GEO) was analyzed using the GEO2R tool. The physical association between the DEGs were mapped using the STRING tool and was visualized in the Cytoscape software. The enriched functional processes were identified with the ClueGO plugin's help from Cytoscape. Further integrative functional annotation was performed by implying the GeneGo Metacore (TM) to distinguish the enriched pathway maps, process networks, and GO processes. The results from this analysis revealed the critical signaling cascades that have been either activated or inhibited due to identified DEGs. We found the activated pathways such as immune response IL-1 signaling pathway, positive regulation of smooth muscle migration, BMP signaling pathway, positive regulation of leukocyte migration, NIK/NF-kappB signaling, and cytochrome-c oxidase activity. Finally, we mapped four crucial genes (CCL5, ALK, TAC1, CD74, and HLA-DOA) by comparing the functional annotations that could be significantly influential in emphysema molecular pathogenesis. Our study provides insights into the pathogenesis of emphysema and helps in developing potential drug targets against emphysema.
引用
收藏
页码:315 / 342
页数:28
相关论文
共 50 条
  • [41] The Distribution of Alpha-1 Antitrypsin Genotypes Between Patients with COPD/Emphysema, Asthma and Bronchiectasis
    Veith, Martina
    Tuffers, Julia
    Peychev, Erika
    Klemmer, Andreas
    Kotke, Viktor
    Janciauskiene, Sabina
    Wilhelm, Susanne
    Bals, Robert
    Koczulla, Andreas Rembert
    Vogelmeier, Claus Franz
    Greulich, Timm
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2020, 15 : 2827 - 2836
  • [42] Fev1 Decline, CT Emphysema And Air Trapping In Patients With Alpha-1 Antitrypsin Deficiency
    Paoletti, L.
    Krowchuk, N.
    Yin, Y.
    Dawod, Y.
    Argula, R. G.
    Brantly, M. L.
    Stoller, J. K.
    Sandhaus, R. A.
    Trapnell, B. C.
    Silverman, E. K.
    Barker, A. F.
    Strange, C. B.
    Coxson, H. O.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [43] Chymotrypsin-like Elastase-1 Mediates Progressive Emphysema in Alpha-1 Antitrypsin Deficiency
    Devine, Andrew J.
    Smith, Noah J.
    Joshi, Rashika
    Fan, Qiang
    Borchers, Michael T.
    Clair, Geremy C.
    Adkins, Joshua N.
    Varisco, Brian M.
    CHRONIC OBSTRUCTIVE PULMONARY DISEASES-JOURNAL OF THE COPD FOUNDATION, 2023, 10 (04): : 380 - 391
  • [44] Rate Of FEV1 Decline In Alpha-1 Antitrypsin (A1AT) Deficiency Decreases With Severity Of Emphysema
    Anderson, T.
    Wewers, M. D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [45] Hiv-related emphysema and alpha1-antitrypsin deficiency: A pilot study
    Sethi, Sonali
    Tietjen, Patricia A.
    Berna, Gioiamaria B.
    Smith, Adam J.
    Brantley, Mark
    Cicenia, Joseph C.
    CHEST, 2007, 132 (04) : 491S - 491S
  • [46] Anti-Elastin Autoimmunity in Emphysema Related to alpha 1 Antitrypsin Deficiency (AATD)
    Wood, A. M.
    Ahmad, A.
    Stockley, R. A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [47] Pulmonary Emphysema in a Child With Alpha-1 Antitrypsin Deficiency: Evaluation of 2 Years of Intravenous Augmentation Therapy
    Brandao, Maria Esteves
    Conde, Bebiana
    Seixas, Susana
    Silva, Joelma Clotilde
    Fernandes, Ana
    ARCHIVOS DE BRONCONEUMOLOGIA, 2019, 55 (09): : 502 - 504
  • [48] Personalised indication of augmentation therapy for emphysema associated with severe alpha-1 antitrypsin deficiency: a case series
    Aljama, Cristina
    Martin, Teresa
    Granados, Galo
    Miravitlles, Marc
    Barrecheguren, Miriam
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2024, 18
  • [49] Unique and shared systemic biomarkers for emphysema in Alpha-1 Antitrypsin deficiency and chronic obstructive pulmonary disease
    Serban, K. A.
    Pratte, K. A.
    Strange, C.
    Sandhaus, R. A.
    Turner, A. M.
    Beiko, T.
    Spittle, D. A.
    Maier, L.
    Hamzeh, N.
    Silverman, E. K.
    Hobbs, B. D.
    Hersh, C. P.
    DeMeo, D. L.
    Cho, M. H.
    Bowler, R. P.
    EBIOMEDICINE, 2022, 84
  • [50] Activation of complement component 3 is associated with airways disease and pulmonary emphysema in alpha-1 antitrypsin deficiency
    O'Brien, Michael E.
    Fee, Laura
    Browne, Niall
    Carroll, Tomas P.
    Meleady, Paula
    Henry, Michael
    McQuillan, Karen
    Murphy, Mark P.
    Logan, Mark
    McCarthy, Cormac
    McElvaney, Oliver J.
    Reeves, Emer P.
    McElvaney, Noel G.
    THORAX, 2020, 75 (04) : 321 - 330